
|Articles|December 1, 2002
The American Journal of Managed Care
- December 2002
- Volume 8
- Issue 12
Economic Evaluation of Enoxaparin as Prophylaxis Against Venous Thromboembolism in Seriously Ill Medical Patients: A US Perspective
Author(s)Gregory de Lissovoy, PhD, Prasun Subedi, BS
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Patients With CKD Are Less Likely to Receive Adjuvant Chemotherapy
2
FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss
3
Top 5 Most-Read Heart Failure Content of 2025
4
Overcoming Pain Points to Advance Bispecifics in the Community for Patients With Myeloma
5







































